Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Selectra Investments Sicav - J Lamarck Pharma A Cap Fonds LU1224032034

116.76 EUR
2.68 EUR
2.35 %
5.2.2025
NAV

Nettoinventarwert (NAV)

116.76 EUR 2.68 EUR 2.35 %
Vortag 114.08 EUR Datum 05.02.2025

Selectra Investments Sicav - J Lamarck Pharma A Cap Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 388.08%
21Shares Stellar ETP CH1109575535 262.62%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Algorand ETP CH1146882316 160.84%
21Shares The Sandbox ETP CH1177361008 134.26%
21Shares Sui Staking ETP CH1360612159 84.39%
21Shares Injective Staking ETP CH1360612134 -16.01%
21Shares Immutable ETP CH1360612142 -23.58%
Name ISIN Performance
21Shares Sui Staking ETP CH1360612159 442.24%
21Shares Ripple XRP ETP CH0454664043 411.84%
21Shares Stellar ETP CH1109575535 290.27%
21Shares Aave ETP CH1135202120 197.58%
21Shares Algorand ETP CH1146882316 170.14%
21Shares Stacks Staking ETP CH1258969042 145.10%
21Shares Injective Staking ETP CH1360612134 -28.15%
21Shares Immutable ETP CH1360612142 -37.27%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 386.55%
21Shares Aave ETP CH1135202120 212.40%
21Shares Stellar ETP CH1109575535 206.11%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 184.30%
21Shares Bitcoin Core ETP CH1199067674 129.92%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 743.17%
21Shares Ripple XRP ETP CH0454664043 481.66%
21Shares Bitcoin Core ETP CH1199067674 313.98%
21Shares Bitcoin ETP CH0454664001 303.50%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 275.02%

Fundamentaldaten

Valor
ISIN LU1224032034
Emittent J. Lamarck Asset Management
Aufgelegt in Luxembourg
Auflagedatum 30.06.2015
Kategorie Branchen: Gesundheitswesen
Währung EUR
Volumen 6’368’000.07
Depotbank Quintet Private Bank (Europe) S.A.
Geschäftsjahresende 31.12.
Berichtsstand 04.02.2025

Anlagepolitik

So investiert der Selectra Investments Sicav - J Lamarck Pharma A Cap Fonds: The main objective of this Sub-Fund is to profit from increasing share prices in the pharmaceutical sector worldwide. The focus is on mature top tier pharmaceutical companies and companies with interesting pipeline of products in development in a single or numerous markets. The followed investment policy will enable the Sub-Fund to increase overall return by active stock selection of companies, offering the most promising technology platform.

ETP Performance: Selectra Investments Sicav - J Lamarck Pharma A Cap Fonds

Performance 1 Jahr
-2.14
Performance 2 Jahre
1.30
Performance 3 Jahre
6.11
Performance 5 Jahre
21.85
Performance 10 Jahre -